blfs_8k.htm
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 12, 2015
Date of report (Date of earliest event reported)
____________________________________
BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware |
|
0-18710 |
|
94-3076866 |
| (State or Other Jurisdiction of Incorporation) |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)
(425) 402-1400
(Registrant’s telephone number, including area code)
____________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On January 12, 2015, BioLife Solutions, Inc. (the “Company”) issued a press release announcing the preliminary financial results of the Company for the fiscal year ended December 31, 2014. The Company has announced preliminary revenue of approximately $6.3 million, of which approximately $4.9 million was attributable to proprietary product revenue and approximately $1.4 million was attributable to contract manufacturing services. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No.
|
|
Description
|
| |
|
|
|
|
|
Press release dated January 12, 2015
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
BIOLIFE SOLUTIONS, INC.
|
|
| |
|
|
|
|
|
By:
|
/s/ Daphne Taylor |
|
| |
|
Daphne Taylor
|
|
| |
|
Chief Financial Officer
|
|
| |
|
|
|
|
Exhibit No.
|
|
Description
|
| |
|
|
|
|
|
Press release dated January 12, 2015
|